MedTrace Logo

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

NCT00899028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 689

Last updated 2017-04-20

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue, blood, sputum, and urine from patients with lung cancer and from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is looking at biomarkers for lung cancer using tissue samples from patients with lung cancer and from healthy participants.

Conditions

Interventions

GENETIC

comparative genomic hybridization

GENETIC

fluorescence in situ hybridization

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

protein expression analysis

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

matrix-assisted laser desorption/ionization time of flight mass spectrometry

OTHER

medical chart review

PROCEDURE

diagnostic bronchoscopy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Pierre P. Massion, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-05-31
Primary Completion
2015-08-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00899028 on ClinicalTrials.gov